FIELD: medicine.
SUBSTANCE: invention refers to method of antiarhythmic episode treatment and/or prevention in human, preferentially with conversion of recent onset atrial fibrillation (Afib) or normal sinus rhythm (NSR) flutters in the patients, including step, completely discontinuous or partially continuous introduction of a liquid pharmaceutical composition containing therapeutically effective amount of 3,7-diazabicyclo[3,3,1]nonane derivatives of formula (1)
EFFECT: more effective treatment.
14 cl, 1 dwg, 9 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIARRHYTHMIC PREPARATION | 1999 |
|
RU2185159C2 |
AGENT POSSESSING ANTIARRHYTHMIC, ANTIFIBRILLATORY, ANTI-ISCHEMIC ACTION, AND BASED PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2477130C1 |
3-PHENYL-3,7-DIAZABICYCLO[3,3,1]NONANE COMPOUNDS, METHOD FOR THEIR PREPARING AND MEDICINAL AGENTS CONTAINING THESE COMPOUNDS | 2002 |
|
RU2299210C2 |
METHOD FOR SINUS RHYTHM RESTORATION IN ATRIAL FLUTTER TYPE 1 | 2010 |
|
RU2448698C2 |
METHOD FOR PREVENTION OF CARDIAC RHYTHM DISTURBANCE IN CORONARY BYPASS | 2009 |
|
RU2392939C1 |
METHOD FOR TREATING ATRIAL FIBRILLATION IN CASE OF MYOCARDIAL INFARCTION | 2005 |
|
RU2268713C1 |
METHOD FOR EVALUATING THE EFFECT OF PROPHYLACTIC ANTI-ARRHYTHMIC THERAPY IN PATIENTS WITH FREQUENT PAROXYSMS OF ATRIAL FIBRILLATION AND FLUTTER ACCORDING TO DATA OF SPONTANEOUS RELAPSES OF ARRHYTHMIA | 2006 |
|
RU2315551C2 |
METHOD FOR PREVENTION OF RECURRENT ATRIAL FIBRILLATION FOLLOWING CARDIOSURGICAL OPERATIONS | 2014 |
|
RU2567920C1 |
PROLONGED-RELEASE ORAL TEDISAMIL COMPOSITION RETAINED IN STOMACH | 2005 |
|
RU2385724C2 |
METHOD FOR BLOCKING ATRIAL FLUTTER | 0 |
|
SU1683678A1 |
Authors
Dates
2009-06-20—Published
2003-11-17—Filed